GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shedir Pharma Group SpA (MIL:SHE) » Definitions » Capital Expenditure

Shedir Pharma Group SpA (MIL:SHE) Capital Expenditure : €-4.36 Mil (TTM As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shedir Pharma Group SpA Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Shedir Pharma Group SpA's cash flow for capital expenditures for the six months ended in Jun. 2024 was €-0.45 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2024 was €-4.36 Mil.


Shedir Pharma Group SpA Capital Expenditure Historical Data

The historical data trend for Shedir Pharma Group SpA's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shedir Pharma Group SpA Capital Expenditure Chart

Shedir Pharma Group SpA Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial -2.47 -1.19 -2.28 -1.47 -5.68

Shedir Pharma Group SpA Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.44 -1.03 -1.77 -3.91 -0.45

Shedir Pharma Group SpA Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-4.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shedir Pharma Group SpA Business Description

Traded in Other Exchanges
N/A
Address
95 - Piano di Sorrento, Via Bagnulo, Naples, ITA, 80063
Shedir Pharma Group SpA is engaged in manufacturing of nutraceuticals, cosmetics and medical devices. Its products are divided into four lines Shedir , Deimos, Phobos, and Menkar. The company's products include capsules, softgels, swallowable and chewable tablets, orosoluble powders, granules, oral solutions, drops for oral use, sprays for oral, sublingual and nasal use, Creams and gels for cosmetic use, and Spray for topical use.

Shedir Pharma Group SpA Headlines